FDA NDC Directory · JSON-LD · Markdown

RiaSTAP

NDC 63833-891 · PLASMA DERIVATIVE · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Generic nameFIBRINOGEN HUMAN
Labeler / ManufacturerCSL Behring GmbH
Marketing categoryBiologic License Application · App BLA125317
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsFIBRINOGEN HUMAN (1300 mg/50mL)
Marketing started20090116
Package count1

External sources

Source: openFDA. Public-domain (CC0).